Cannabismarketcap

Compare Amplify Seymour Cannabis ETF (CNBS) With Other Cannabis Stocks

Head-to-head stock comparisons across price, valuation, financials, and growth metrics

Company

Amplify Seymour Cannabis ETF (CNBS)

Price

$23.48

Change

-0.63%

Market Cap

$75.3M

Sector

ETF

ETF Sector Peers

All ETF cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.

TickerNamePriceChange %MCap
MSOSAdvisorShares Pure US Cannabis ETF$4.05+0.25%$781.2M
MJETFMG Alternative Harvest ETF$22.48+0.58%$113.0M
YOLOAdvisorShares Pure Cannabis ETF$2.56-0.78%$30.4M
HMLSFGlobal X Marijuana Life Sciences ETF$4.630.00%$22.8M
WEEDRoundhill Cannabis ETF$19.24-0.40%$8.8M

Top Matchups by Market Cap

Companies closest to Amplify Seymour Cannabis ETF in market capitalization — the most meaningful head-to-head comparisons.

AAWHMSO

Ascend Wellness Holdings

MCap: $81.1M

$0.40+0.98%
Compare
AFCGREIT

AFC Gamma (Advanced Flower Capital)

MCap: $67.1M

$2.990.00%
Compare
CWBHFCBD

Charlotte's Web Holdings

MCap: $64.6M

$0.24-1.33%
Compare
GRWGAncillary

GrowGeneration

MCap: $87.8M

$1.50+2.04%
Compare
LOVFFLP

Cannara Biotech

MCap: $92.4M

$1.43-0.28%
Compare

Cross-Sector Comparisons

Top cannabis companies outside the ETF sector. Compare across different business models and market segments.

JAZZBiotech

Jazz Pharmaceuticals

MCap: $13.30B

$205.06-0.83%
Compare
SMGAncillary

Scotts Miracle-Gro

MCap: $3.46B

$59.66+0.51%
Compare
CURLFMSO

Curaleaf Holdings

MCap: $2.14B

$8.48-0.12%
Compare
TRLVMSO

Trulieve Cannabis

MCap: $2.08B

$10.62-0.47%
Compare
GTBIFMSO

Green Thumb Industries

MCap: $1.54B

$6.41+0.16%
Compare

Comparing CNBS in the Cannabis Market

Amplify Seymour Cannabis ETF (CNBS) is a cannabis exchange-traded fund (ETF)trading at $23.48 per share with a market capitalization of $75.3M. Among its ETF peers, CNBS ranks #3 by market cap. The stock has moved -0.63% in the current session, trading on the NYSE exchange.

When comparing CNBS against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio, revenue growth, and balance sheet strength. The comparison tables above allow you to evaluate Amplify Seymour Cannabis ETF relative to 5 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.

Frequently Asked Questions

How does CNBS compare to other ETF stocks?+
Amplify Seymour Cannabis ETF has a market cap of $75.3M, placing it among 6 companies in the ETF sector. Use the table above to compare these metrics against every ETF peer.
What is CNBS's biggest competitor?+
By market capitalization, the closest comparable company is Ascend Wellness Holdings (AAWH) with a market cap of $81.1M. Click the compare link to view a full head-to-head analysis.
Is CNBS overvalued compared to its peers?+
Amplify Seymour Cannabis ETF has no reported price-to-sales ratio in our data, because trailing revenue is not available. Compare this to sector peers in the table above to determine relative valuation. A lower P/S may indicate relative value, while a higher P/S may reflect growth expectations.
Which cannabis stock has better margins than CNBS?+
Amplify Seymour Cannabis ETF does not report a gross margin in our data, so it cannot be ranked against peers on margins yet.
Can I compare CNBS to stocks in other cannabis sectors?+
Yes. The Cross-Sector Comparisons section above features top companies from sectors outside ETF. You can click any company to see a full side-by-side comparison with CNBS covering price, valuation, financials, and growth metrics.

All CNBS Comparisons

Every available head-to-head comparison for Amplify Seymour Cannabis ETF.

Related Pages

Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.